About Us

About Us

About Epicadence, Public Benefit Corporation

Epicadence, a Public Benefit Corporation, is a Salt Lake City-based and Delaware-incorporated company formed in April 2015. We are a digital medicine company developing mobile apps and software as medical device therapies for people with epilepsy. The technology has been developed at the University of Utah, led by Epicadence scientific cofounders, Professors Carol Bruggers, MD (School of Medicine) and Grzegorz Bulaj, PhD (College of Pharmacy) and in collaboration with clinical faculty Professors Pegah Afra and Matthew Sweney from the Department of Neurology.

About Our Team

The Epicadence team has a cumulative experience of over 155 years in entrepreneurship, therapy development, health care, clinical, software, regulatory, legal, and community operations:

Grzegorz Bulaj, PhD, Chief Executive Officer, cofounder; over 18 years of entrepreneurial and drug development experience in epilepsy and pain, co-founder of two companies NeuroAdjuvants Inc and Epicadence PBC; former Director of Peptide Chemistry in Cognetix, Inc., involved in preclinical and clinical development of antiseizure and analgesic drugs. He has coauthored over 120 publications and is a coinventor on several issued/pending patents.  He received his PhD degree in biochemistry from the University of Wroclaw, Poland. He is currently an Associate Professor of Medicinal Chemistry and Entrepreneurial Faculty Scholar at the University of Utah. Drs. Bulaj and Bruggers have been working together on digital medicine technologies since 2010.

Carol S. Bruggers, MD, Chief Medical Officer, cofounder; Professor of Pediatric Hematology-Oncology at the University of Utah School of Medicine, where she has worked for over 25 years. She received her BA, MA and MD degrees from Denison University, Stanford University, and Michigan State University, respectively; completed her Pediatric residency at the University of Colorado and her Pediatric Hematology-Oncology fellowship at Duke University; and is Board-Certified in Pediatrics and Pediatric Hematology-Oncology. Her primary focus involves comprehensive clinical care of children and teens with diverse cancers from diagnosis through survivorship, with an emphasis in Pediatric Neuro-Oncology.  She is committed to clinical and translational research, has over 40 peer-reviewed publications, and is a Reviewer for several peer review journals. She has collaborated with Dr. Bulaj to develop digital medical technologies. She is a co-inventor of a Disease Therapy Game Technology patent and has presented exercise-empowerment video game technology for pediatric oncology patients at national meetings.

Keith Gordon, BSc Behavioral Sci and Health Administration, consultant, management, over 17 years of experience as CEO and executive director in health care companies; Former CEO of Legacy Healthcare Inc, national analyst and transitional executive director of Odyssey Health Care inc, executive director Utah Heritage Hospice, Inc, Post-Graduate: Gerontology, University of Utah. Senior level operations management professional with a proven record of developing actionable plans, and measurable results for companies facing competitive market challenges. Adept at building processes and procedures that improve productivity, control costs and increase profitability. Track record of ensuring operational and technological services are optimized to drive innovation and growth. Change-agent with exceptional communication and leadership abilities skilled realigning cultures and quickly building esprit de corps organization-wide for maximum results.

Patrick A. Shea, MA, JD, VP and General Counsel, cofounder; Research Professor of Biology, over 41 years of experience in legal/government and academic-industry affairs; BA from Stanford in Intellectual History, MA from Oxford in genetics and animal behavior, JD from Harvard. As the principal of Patrick A Shea, PC, he and his firm specialize in business, development, government and environmental law.  Mr. Shea is committed to solving business problems which involve legal, political and economic questions. Mr. Shea maintains Bar membership in the District of Columbia and Utah, and is admitted to practice before the 1Oth Circuit Federal Court of Appeals and the United States Supreme Court.  Past key positions in Washington DC included an assistant to the Staff Director of the Senate Select Committee on Intelligence Operations, Counsel to the United States Senate Foreign Relations Committee, National Director of the Bureau of Land Management.

Krzysztof Szewczuk, MEng, Chief Community Officer, over 21 years of experience in leadership, project management, business/community operations; engineering degree from the Main School of Fire Service, Warsaw, Poland and he was a Chief of Fire Department; arrived to the US as a political refugee (due to repressions from the Polish communistic government in 1980s). Mr Szewczuk served in the Avenues to Independence by helping children with Down Syndrome and cerebral palsy, also volunteered in hospices in Chicago. In Utah, he is CEO of a small publishing company, and manages vacation Alta-House.

Phil Triolo, PhD, RAC, Chief Regulatory Officer has over 35 years of industrial and regulatory experience in the medical device industry. A biomedical engineer by training, Phil worked as a contract medical device development engineer until he founded Phil Triolo and Associates in 1997 to help medical device companies meet their regulatory obligations. Phil specializes in pre-market submissions and quality systems necessary for product introductions in the US, EU (CE Marking) and Canada. He is a fellow of the American Institute of Medical and Biological Engineering and adjunct Associate Professor of Bioengineering at the University of Utah where he lectures to BioInnovate students on FDA medical device regulations. He is a past COB of Splore, an organization that provides outdoor recreational opportunities for persons with disabilities, and plays sax in several bands that donate their time to Heart and Soul, an NPO that brings music to individuals with limited mobility.

Pegah Afra, MD, Dr. Afra is an Associate Professor of Neurology and Program Director of Clinical Neurophysiology and Epilepsy Fellowship Programs in University of Utah’s Department of Neurology. She received her medical training in Albert Szent Gyorgyi Medical University in Szeged, Hungary.  She then completed her internship in internal medicine in Southern Illinois University, three years of neurology residency in University of Wisconsin, and two years of fellowship in epilepsy and clinical neurophysiology in Johns Hopkins Hospital.  She is currently Board-Certified in Neurology, Clinical Neurophysiology and Epilepsy. She focuses her practice on diagnosis and treatment of adults and adolescents with seizures and epilepsy. Her interests include treatment of intractable epilepsies including evaluation for seizure surgery and neurostimulation devices for epilepsy, seizures that have been difficult to diagnose or have not responded to medications. During her research time Dr. Afra conducts clinical trials in epilepsy, which include novel upcoming neurostimulation devices and pharmacologic agents. She also investigates the dynamics of intracranially recorded seizures, and the basis of variations of human cognitive function including synesthesia. She has a genuine interest in digital technologies and music therapy as a non-invasive modality to help improve seizure control and state of well-being.

Matthew Sweney, MD, MS, clinical faculty, pediatric neurologist, epileptologist; Dr. Sweney is a pediatric neurologist who focuses on the diagnosis and treatment of drug-resistant pediatric epilepsy. He is Medical Director of the Comprehensive Pediatric Epilepsy Program at Primary Children’s Hospital. He is board certified in Pediatrics, Neurology, Epilepsy, and Clinical Neurophysiology. He participates in all aspects of pediatric epilepsy care, including medication management, non-medication alternatives such as ketogenic diet and vagal nerve stimulation, and palliative and curative epilepsy surgery. He remains active in ongoing studies into new potential anti-seizure medications and is committed to providing the most advanced care to children of the intermountain region suffering from epilepsy.

Jeremiah Jones, Chief Technology Officer, President Stretto Consulting, software technology; Jeremiah is a technology entrepreneur and startup consultant. His technical career includes roles such as: lead technologist, principle engineer, enterprise architect, and chief technology officer. He has been the founder, co-founder, or advisor to several startups and currently serves in resident entrepreneurship and mentoring roles at local universities. With a BS in IT, MS in Technology, and an MBA, he is passionate about education and the importance of technology careers to the world economy. He is also a classical pianist with more than 37 million downloads of his music recordings.

Gerry Garcia, Greatful Living Productions, musician, screenwriter and music director at Kearns St. Ann School. He began playing piano at the age of three and has since utilized his musical abilities in competitions, concerts, and in film work. At the age of 19, he founded his own production company, Greatful Living Productions. He has worked on multiple films and television shows working his way up to set coordinating and script supervision. Aside from film, he has used his knowledge in music and epilepsy (due to his sister who has intractable epilepsy) to create an antiseizure music playlist in collaboration with Dr. Bulaj. Gerry continues writing screenplays for the silver screen and is working on a degree in marketing while he is directing the music program at his school.

Tom Lamar, Founder and Managing Director of LaunchSail.com, a Silicon Valley based business intelligence consulting agency. Mr. Lamar, also a Strategic Industry Advisor to a number of Artificial Intelligence companies, has participated in the formation and executive leadership of a number of successful companies in the fields of software, industrial design, healthcare technology and search engine infrastructure. He was a Cofounder of Inktomi Corporation [INKT] ($24B market cap; acquired by Yahoo!) and played a key role in its scaling and overall success. In this current role, at Node.io, Mr. Lamar is responsible for fundraising, corporate development, and recruiting. He specializes in providing business intelligence, mergers and acquisition guidance, strategic introductions, and intellectual capital. He holds a Bachelor of Science in Industrial Design from The Georgia Institute of Technology and is a trained blacksmith and a knowledgeable industrial designer. His passion is his 18-year-old daughter and racing stand up paddleboards in the San Francisco Bay.

Larry Kane, JD, Partner in Orrick, supporting corporate and legal affairs.